List of Contributors xv
Preface xix
<b>Part I Fundamentals of Chiral Separation 1</b>
<b>1 Chiral Separation by LC 3
</b><i>Juliana Cristina Barreiro and Quezia Bezerra Cass</i>
1.1 Introduction 3
1.2 Workflow for LC Chiral Method Development 7
1.3 New Column Technologies 9
1.4 Selected Examples of Fast Separation 12
1.5 Chiral 2D-LC 14
1.5.1 LC-LC and mLC-LC 14
1.5.2 LC x LC and sLC x LC 17
1.6 Future and Perspectives 19
References 20
<b>2 Chiral Separation by GC 27
</b><i>Oliver Trapp</i>
2.1 Introduction 27
2.2 Chiral Recognition in Gas Chromatography 29
2.2.1 Chiral Recognition by Hydrogen Bonding 31
2.2.2 Chiral Recognition Using Chiral Metal Complexes 31
2.2.3 Chiral Recognition by Host-Guest Interactions 31
2.3 Preparation of Fused-Silica Capillaries for GC with CSPs 33
2.4 Application of CSPs in Chiral Gas Chromatography 34
2.4.1 CSPs with Diamide Selectors 34
2.4.1.1 Chirasil-Val 34
2.4.2 CSPs with CD Selectors 35
2.4.2.1 Heptakis(2,3,6-tri-<i>O</i>-Methyl)-?-Cyclodextrin(Permethyl-?-Cyclodextrin) 38
2.4.2.2 Heptakis(2,3,6-tri-<i>O</i>-Methyl)-?-Cyclodextrin Immobilized to Hydrido Dimethyl Polysiloxane (Chirasil-?-Dex) 39
2.4.2.3 Heptakis(2,6-di-<i>O</i>-Methyl-3-<i>O</i>-Pentyl)-?-Cyclodextrin 43
2.4.2.4 Hexakis-(2,3,6-tri-<i>O</i>-Pentyl)-?-Cyclodextrin 47
2.4.2.5 Heptakis(2,3,6-tri-<i>O</i>-Pentyl)-?-Cyclodextrin 48
2.4.2.6 Hexakis-(3-<i>O</i>-Acetyl-2,6-di-<i>O</i>-Pentyl)-?-Cyclodextrin 51
2.4.2.7 Heptakis(3-<i>O</i>-Acetyl-2,6-di-O-Pentyl)-?-Cyclodextrin 51
2.4.2.8 Octakis(3-<i>O</i>-Butyryl-2,6-di-O-Pentyl)-?-Cyclodextrin 53
2.4.2.9 Hexakis/Heptakis/Octakis(2,6-di-O-Alkyl-3-O-Trifluoroacetyl)-?/?/?-Cyclodextrins 57
2.4.2.10 Heptakis(2,3-di-<i>O</i>-Acetyl-6-<i>O</i><i>-</i><i>tert</i>-Butyldimethylsilyl)-?-Cyclodextrin (DIAC-6-TBDMS-?-CD) 58
2.4.2.11 Heptakis(2,3-di-<i>O</i>-Methyl-6-<i>O</i><i>-</i><i>tert</i>-Butyldimethylsilyl)-?-Cyclodextrin (DIME-6-TBDMS-?-CD) 58
2.4.3 Cyclofructans 62
2.4.4 CSPs with Metal Complexes 65
2.5 Conclusion 69
References 69
<b>3 Chiral Separation by Supercritical Fluid Chromatography 85
</b><i>Emmanuelle Lipka</i>
3.1 Introduction 85
3.2 Characteristics and Properties of Supercritical Fluids 87
3.3 Development of a Chiral SFC Method 89
3.3.1 Chiral Stationary Phases 89
3.3.2 Mobile Phases 91
3.3.2.1 Mobile Phase: Type of Co-solvent Used 93
3.3.2.2 Mobile Phase: Percentage of Co-solvent Used 94
3.3.2.3 Mobile Phase: Use of Additives 94
3.4 Operating Parameters 94
3.4.1 Effect of the Flow Rate 95
3.4.2 Effect of the Outlet Pressure (Back-pressure) 95
3.4.2.1 Effect of Pressure When the Mobile Phase is a Gas-Like Fluid 96
3.4.2.2 Effect of Pressure When the Mobile Phase is a Liquid-Like Fluid 97
3.4.3 Effect of Temperature 97
3.4.3.1 Effect of Temperature When the Mobile Phase is a Gas-LikeFluid 98
3.4.3.2 Effect of Temperature When the Mobile Phase is a Liquid-Like Fluid 98
3.5 Detection 99
3.6 Scale-Up to Preparative Separation 99
3.7 Conclusion 100
References 101
<b>4 Chiral Separation by Capillary Electrophoresis and Capillary Electrophoresis-Mass Spectrometry: Fundamentals, Recent Developments, and Applications 103
</b><i>Charles Clark, Govert W. Somsen, and Isabelle Kohler</i>
4.1 Introduction 103
4.2 Principles of Chiral CE 105
4.2.1 Electrophoretic Mobility 105
4.2.2 CE Separation Efficiency 106
4.2.3 Chiral Resolution in CE 107
4.2.4 Chiral Micellar Electrokinetic Chromatography and Capillary Electrochromatography 109
4.3 Short History of Chiral CE Modes 111
4.3.1 Chiral CE 111
4.3.2 Chiral MEKC and Chiral CEC 111
4.4 State of the Art and Recent Developments 112
4.4.1 Common Chiral Selectors 112
4.4.2 Ionic Liquids as Chiral Selectors 117
4.4.3 Nanoparticles as Chiral Selector Carriers 117
4.4.4 Microfluidic Chiral CE 118
4.5 Applications of Chiral CE 119
4.5.1 Pharmaceutical Analysis 119
4.5.2 Food Analysis 120
4.5.3 Environmental Analysis 121
4.5.4 Bioanalysis 123
4.5.5 Forensic Analysis 126
4.6 Chiral CE-MS: Strategies and Challenges 126
4.6.1 Hyphenation Approaches 129
4.6.1.1 Sheath-Liquid and Sheathless CE-MS Interfacing 129
4.6.1.2 Partial-Filling Techniques 130
4.6.1.3 Counter-Migration Techniques 131
4.6.2 Chiral MEKC-MS 132
4.6.3 Chiral CEC-MS 133
4.7 Conclusions and Perspectives 135
References 135
<b>5 Chiral Separations at Semi and Preparative Scale 143
</b><i>Larry Miller</i>
5.1 Introduction 143
5.2 Selection of Operating Conditions 145
5.3 Batch HPLC Purification 146
5.3.1 Analytical Method Development for Preparative Separations 146
5.3.2 Batch HPLC Examples 148
5.3.2.1 Batch HPLC Example 1 148
5.3.2.2 Batch HPLC Example 2 149
5.4 Steady-State Recycle Introduction 151
5.4.1 SSR Example 1 153
5.5 Simulated Moving Bed Chromatography - Introduction 154
5.5.1 SMB Examples for R&D and Separation of Compound 2 156
5.5.2 Development of a Manufacturing SMB Process (Compound 1) 158
5.5.3 Cost for SMB Processes 160
5.6 Introduction to Supercritical Fluid Chromatography 161
5.6.1 Analytical Method Development for Scale-up to Preparative SFC 162
5.6.2 Preparative SFC Example 1 163
5.6.3 Preparative SFC Example 2 163
5.7 Options for Increasing Purification Productivity 165
5.7.1 Closed-Loop Recycling 165
5.7.2 Stacked Injections 166
5.7.3 Choosing the Best Synthetic Intermediate for Separation 167
5.7.3.1 Choosing Synthetic Step for Separation - HPLC/SMB Example 168
5.7.3.2 Choosing Synthetic Step for Separation - SFC Example 169
5.7.4 Use of Non-Commercialized CSP 170
5.7.5 Immobilized CSP for Preparative Resolution 173
5.7.5.1 Processing of Low Solubility Racemate 173
5.7.5.2 Preparative Resolution of EMD 53986 174
5.8 Choosing a Technique for Preparative Enantioseparation 176
5.9 Conclusion 178
References 179
<b>Part II Chiral Selectors 187</b>
<b>6 Polysaccharides 189
</b><i>Weston Umstead, Takafumi Onishi, and Pilar Franco</i>
6.1 Introduction 189
6.2 The Early Years 190
6.3 Polysaccharide Chiral Separation Mechanism 193
6.4 Coated Chiral Stationary Phases 197
6.5 Immobilized Chiral Stationary Phases 201
6.6 Applications of Polysaccharide-Derived CSPs 208
6.6.1 Analytical Applications 210
6.6.1.1 Pharmaceuticals 211
6.6.1.2 Agrochemicals 218
6.6.1.3 Food Analysis 219
6.6.2 Preparative Applications 220
6.7 Summation 224
References 224
<b>7 Macrocyclic Antibiotics and Cyclofructans 247
</b><i>Saba Aslani, Alain Berthod, and Daniel W. Armstrong</i>
7.1 Introduction 247
7.2 Macrocyclic Glycopeptides Physicochemical Properties 248
7.3 Using the Chiral Macrocyclic Glycopeptides Stationary Phases 253
7.3.1 Mobile Phases and Chromatographic Modes 253
7.3.2 Chromatographic Enantioseparations 254
7.3.2.1 Amino Acids and Peptides 254
7.3.2.2 Chiral Compounds 257
7.3.2.3 Particle Structure 257
7.4 Using and Protecting Macrocyclic Glycopeptide Chiral Columns 260
7.4.1 Operating Conditions 260
7.4.2 Storage 261
7.5 Cyclofructans 261
7.5.1 Cyclofructan Structure and Properties 261
7.5.2 Chiral Separations with Cyclofructan-Based Stationary Phases 264
7.5.3 Cyclofructan Stationary Phases Used in the HILIC Mode 264
7.5.4 Cyclofructan Stationary Phases Used in Supercritical Fluid Chromatography 266
7.6 Conclusions 267
References 268
<b>8 Cyclodextrins 273
</b><i>Gerhard K. E. Scriba, Mari-Luiza Konjaria, and Sulaiman Krait</i>
8.1 Introduction 273
8.2 Structure and Properties 274
8.3 Cyclodextrin Complexes 279
8.4 Application in Separation Science 288
8.4.1 Gas Chromatography 288
8.4.1.1 Types of Cyclodextrins 289
8.4.1.2 Types of Columns 289
8.4.1.3 Separation Mechanisms 291
8.4.1.4 Applications 293
8.4.2 Thin-Layer Chromatography 294
8.4.3 High-Performance Liquid Chromatography 294
8.4.3.1 Types of Columns 295
8.4.3.2 Types of Cyclodextrins 297
8.4.3.3 Separation Mechanisms 298
8.4.3.4 Applications 300
8.4.4 Supercritical Fluid Chromatography 300
8.4.5 Capillary Electromigration Techniques 301
8.4.5.1 Types of Cyclodextrins 301
8.4.5.2 Separation Mechanisms 302
8.4.5.3 Migration Modes and Enantiomer Migration Order Using CDs as Selectors 304
8.4.5.4 Applications 310
8.4.6 Membrane Technologies 312
8.5 Miscellaneous Applications 314
8.6 Conclusions and Outlook 315
References 315
<b>9 Pirkle Type 325
</b><i>Maria Elizabeth Tiritan, Madalena Pinto, and Carla Fernandes</i>
9.1 Introduction 325
9.2 CSPs Developed by Pirkle's Group: Chronological Evolution 327
9.3 Pirkle-Type CSPs Developed by Other Research Groups 334
9.4 Example of Applications in Analytical and Preparative Scales 340
9.4.1 Analytical Applications 341
9.4.2 Preparative Applications 349
9.5 Conclusions and Perspectives 349
References 350
<b>10 Proteins 363
</b><i>Jun Haginaka</i>
10.1 Introduction 363
10.2 Preparation of Protein- and Glycoprotein-Based Chiral Stationary Phases 364
10.3 Types of Protein- and Glycoprotein-Based Chiral Stationary Phases 368
10.3.1 Proteins 368
10.3.1.1 Bovine Serum Albumin 368
10.3.1.2 Human Serum Albumin 370
10.3.1.3 Trypsin and ?-Chymotrypsin 372
10.3.1.4 Lysozyme and Pepsin 372
10.3.1.5 Fatty Acid-Binding Protein 373
10.3.1.6 Penicillin G Acylase 375
10.3.1.7 Streptavidin 375
10.3.1.8 Lipase 376
10.3.2 Glycoproteins 376
10.3.2.1 Human ?<sub>1</sub>-Acid Glycoprotein 376
10.3.2.2 Chicken Ovomucoid 377
10.3.2.3 Chicken ?<sub>1</sub>-Acid Glycoprotein 378
10.3.2.4 Avidin 380
10.3.2.5 Riboflavin-Binding Protein and Ovotransferrin 380
10.3.2.6 Cellobiohydrolase 381
10.3.2.7 Glucoamylase 383
10.3.2.8 Antibody (Immunoglobulin G) 385
10.3.2.9 Nicotinic Acetylcholine Receptor and Human Liver Organic Cation Transporter 387
10.4 Chiral Recognition Mechanisms on Protein-and Glycoprotein-Based Chiral Stationary Phases 387
10.4.1 Human Serum Albumin 387
10.4.2 Penicillin G Acylase 389
10.4.3 Human ?<sub>1</sub>-Acid Glycoprotein 390
10.4.4 Turkey Ovomucoid 392
10.4.5 Chicken ?<sub>1</sub>-Acid Glycoprotein 393
10.4.6 Cellobiohydrolase 395
10.4.7 Antibody 396
10.4.8 Nicotinic Acetylcholine Receptor and Human Liver Organic Cation Transporter 400
10.5 Conclusions 401
References 402
<b>11 Chiral Stationary Phases Derived from Cinchona Alkaloids 415
</b><i>Michael Laemmerhofer and Wolfgang Lindner</i>
11.1 Introduction 415
11.2 Cinchona Alkaloid-Derived Chiral Stationary Phases 416
11.3 Chiral Recognition 420
11.4 Chromatographic Retention Mechanisms 424
11.4.1 Multimodal Applicability 424
11.4.2 Surface Charge of Cinchonan-Based CSPs 424
11.4.3 Retention Mechanisms and Models, and Method Development on Chiral WAX CSPs 427
11.4.4 Retention Mechanisms and Method Development on ZWIX CSPs 430
11.5 Structural Variants of Cinchona Alkaloid CSPs and Immobilization Chemistries 436
11.6 Cinchonan-Based UHPLC Column Technologies 442
11.7 Applications 446
11.7.1 Pharmaceutical and Biotechnological Applications 446
11.7.2 Biomedical Applications 453
11.8 Conclusions 460
References 460
<b>Part III Methods for Stereochemical Elucidation 473</b>
<b>12 X-Ray Crystallography for Stereochemical Elucidation 475
</b><i>Ademir F. Morel and Robert A. Burrow</i>
12.1 Introduction 475
12.2 Absolute Structure and Absolute Configuration 476
12.3 Best Practices 482
12.4 Structure Validation 486
12.5 The Absolute Configuration of (+)-Lanatine A 486
12.6 The Absolute Configuration of the Diacetylated Form of Acrenol and the Acetylated Form of Humirianthol 488
12.7 The Absolute Configuration of Ester Form of Clemateol 491
12.8 Relative Configurations of Waltherione A, Waltherione B, and Vanessine 492
12.9 The Absolute Configuration of Condaline A 493
12.10 CSD Deposit Numbers 496
12.11 Conclusions and Future Directions 498
References 498
<b>13 NMR for Stereochemical Elucidation 505
</b><i>Xiaolu Li, Xiaoliang Yang, and Han Sun</i>
13.1 Conventional NMR Methods for Stereochemical Elucidation 505
13.1.1 Determination of the Planar Structure Using 1D <sup>1</sup>H, <sup>13</sup>C NMR (DEPT), 2D HSQC, COSY, TOCSY, HMBC 506
13.1.2 Determination of Relative Configuration Using J-Couplings and NOEs/ROEs 507
13.1.2.1 Scalar Coupling 507
13.1.2.2 NOE/ROE 510
13.1.2.3 Examples of Stereochemical Elucidation Using J-Couplingsand NOEs/ROEs 510
13.2 Determination of the Relative Configuration Using Anisotropic NMR-Based Methods 516
13.2.1 Basic Principles of Anisotropic NMR Parameters 517
13.2.2 Alignment Media 518
13.2.2.1 Preparation of Anisotropic Sample with PMMA Gel 520
13.2.2.2 Preparation of Anisotropic Sample with AAKLVFF 521
13.2.3 Acquisition of the Anisotropic NMR Data 522
13.2.4 Computational Approaches for Analyzing Anisotropic NMR Data 525
13.2.5 Successful Examples of Determination of Relative Configuration of Challenging Molecules Using Anisotropic NMR 528
13.3 Determination of the Relative Configuration Using DP4 Probability and CASE-3D 529
13.4 Determination of the Absolute Configuration Using a Combination of NMR Spectroscopy and Chiroptical Spectroscopy 533
13.5 Determination of the Absolute Configuration Using NMR Alone 534
13.5.1 Mosher Ester Analysis 535
13.5.2 Other Chiral Derivatizing Agents 536
13.6 Future Perspective 536
References 537
<b>14 Absolute Configuration from Chiroptical Spectroscopy 551
</b><i>Fernando Martins dos Santos Junior and Joao Marcos Batista Junior</i>
14.1 Introduction 551
14.2 Chiroptical Methods 554
14.2.1 Optical Rotation and Optical Rotatory Dispersion 554
14.2.1.1 Instrumentation 556
14.2.1.2 Measurements 557
14.2.2 Electronic Circular Dichroism 558
14.2.2.1 Instrumentation 560
14.2.2.2 Measurements 561
14.2.3 Vibrational Circular Dichroism and Raman Optical Activity 561
14.2.3.1 Instrumentation 563
14.2.3.2 Measurements 565
14.2.4 Simulation of Chiroptical Properties 567
14.2.4.1 Common Theoretical Steps 568
14.2.4.2 OR and ORD Simulations 570
14.2.4.3 ECD Simulations 572
14.2.4.4 VCD and ROA Simulations 573
14.2.5 Examples of Application 575
14.2.5.1 OR 575
14.2.5.2 ORD 577
14.2.5.3 ECD 578
14.2.5.4 VCD 579
14.2.5.5 ROA 581
14.2.5.6 Association of Different Chiroptical Methods 582
14.3 Concluding Remarks 585
References 586
Index 593
